Glasgow Early Treatment Arm FavIpiravir (GETAFIX): A randomized controlled study of favipiravir as an early treatment arm in COVID-19 hospitalized patients (COVID-19)

Project: Research

Project Details

StatusActive
Effective start/end date18/05/2017/11/20

Funding

  • Chief Scientist's Office CSO: £22,600.00